Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assessment for Her-2 status in breast cancer

被引：0
|
作者：
Weiguo Sui
Minglin Ou
Jiejing Chen
Youhua Wan
Hongbo Peng
Minfang Qi
He Huang
Yong Dai
机构：
[1] 181st Hospital of People's Liberation Army,Laboratory Center of Guangzhou Military Area Command
[2] Guangxi Normal University,College of Life Science
[3] 181st Hospital of People's Liberation Army,Pathology Department of Guangzhou Military Area Command
来源：
World Journal of Surgical Oncology | / 7卷
关键词：
Trastuzumab; Human Epidermal Growth Factor Receptor; Invasive Ductal Carcinoma; Herceptin; Discordance Rate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Correlation of Her2/neu testing using chromogenic in situ hybridization (CISH) with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) in breast cancer
    Hanna, WM
    Kwok, K
    MODERN PATHOLOGY, 2005, 18 : 35A - 35A
  • [32] Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis
    Lehr, HA
    Jacobs, TW
    Yaziji, H
    Schnitt, SJ
    Gown, AM
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2001, 115 (06) : 814 - 822
  • [33] Fluorescence in situ hybridization (FISH) is superior to immunohistochemistry (IHC) for determining HER2 status:: The Herceptin® experience
    Press, M
    Anderson, S
    Dybdal, N
    Lieberman, G
    Mass, R
    MODERN PATHOLOGY, 2002, 15 (01) : 47A - 48A
  • [34] Fluorescence in situ hybridization (FISH) is superior to immunohistochemistry (IHC) for determining HER2 status:: The Herceptin® experience
    Press, M
    Anderson, S
    Dybdal, N
    Lieberman, G
    Mass, R
    LABORATORY INVESTIGATION, 2002, 82 (01) : 47A - 48A
  • [35] Reliability of chromogenic in situ hybridization for detecting HER-2 gene status in breast cancer:: comparison with fluorescence in situ hybridization and assessment of interobserver reproducibility
    Gong, Y
    Gilcrease, M
    Sneige, N
    MODERN PATHOLOGY, 2005, 18 (08) : 1015 - 1021
  • [36] HER-2 analysis in tissue microarrays of archival human breast cancer - Comparison of immunohistochemistry and fluorescence in situ hybridization
    O'Grady, A
    Flahavan, CM
    Kay, EW
    Barrett, HL
    Leader, MB
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2003, 11 (02): : 177 - 182
  • [37] Fluorescent in situ hybridization (FISH) vs immunohistochemistry (IHC) for determination of Her2/neu status in breast cancer.
    Jimenez, RE
    Wallis, T
    Tabaczka, P
    Visscher, DW
    LABORATORY INVESTIGATION, 1999, 79 (01) : 23A - 23A
  • [38] Comparison of breast cancer HER-2 receptor testing with immunohistochemistry and in-situ-hybridization
    Shanmugalingam, A.
    Hitos, K.
    Pathmanathan, N.
    Edirimmane, S.
    Hughes, M. T.
    Ngui, N. K.
    BREAST, 2023, 68 : S29 - S29
  • [39] Comparison of HER-2/neu status determined by fluorescence in situ hybridization (FISH) in the BCIRG central laboratories with HER-2/neu status determined by immunohistochemistry or FISH in outside laboratories.
    Press, MF
    Sauter, G
    Bernstein, L
    Zhou, J
    Li, B
    Mirlacher, M
    Villalobos, I
    Guzman, R
    Riva, A
    Nabholtz, JM
    Slamon, DJ
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S69 - S69
  • [40] Assessment of HER-2/neu status in breast cancer using fluorescence in situ hybridization & immunohistochemistry: Experience of a tertiary cancer referral centre in India
    Panjwani, Poonam
    Epari, Sridhar
    Karpate, Arti
    Shirsat, Hemlata
    Rajsekharan, Preetha
    Basak, Ranjan
    Shet, Tanuja
    Chinoy, Roshni
    Chacko, Roy
    Gursale, Sampada
    Baraskar, Nayana
    Gupta, Sudeep
    Hawaldar, Rohini
    Desai, Sangeeta
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2010, 132 (03) : 287 - 294
12345